TrialX provides cutting-edge information on new medical treatments and clinical trials in your area.
Meet Dory , your personalized virtual assistant to find clinical trials. Go head, ask her anything. x
All > Ohio Investigators

Esther H. Rehmus, MD

McDowell Cancer Center at Akron ...


Akron, Ohio - 44307 (330-344-6448)
  • CLINICAL TRIALS 31
  • CONDITIONS49
  • INTERVENTIONS65
  • SINCE1991
Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy

June 2008 - December 2009
Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer

July 2009 - June 2012
Oxaliplatin Leucovorin Calcium and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery

June 2010 - February 2013
Adjuvant Doxorubicin Cyclophosphamide and Paclitaxel in Treating Patients With Breast Cancer

November 2003 - June 2012
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery

May 2009 - December 2012
Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB Stage IIIC or Stage IV Breast Cancer

July 2008 - August 2009
Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

April 2008 - January 2010
Bevacizumab and Paclitaxel Paclitaxel Albumin-Stabilized Nanoparticle Formulation or Ixabepilone in Treating Patients With Stage IIIC or Stage IV Breast Cancer

October 2008 - October 2010
Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide

March 2008 - May 2012
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

August 2008 - August 2013
Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance Multiple Myeloma or Plasmacytoma

June 2002 -
Doxorubicin Cyclophosphamide and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk Lymph Node-Negative Breast Cancer

November 2007 - November 2013
Azacitidine With or Without MS-275 in Treating Patients With Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia or Acute Myeloid Leukemia

August 2006 - February 2008
Collecting and Storing Blood and Bone Marrow Samples From Patients With Myeloma Waldenstrom's Macroglobulinemia Amyloidosis or Monoclonal Gammopathy of Undetermined Significance

November 2003 -
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

December 2008 - April 2015
Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I Stage II or Stage IIIA Breast Cancer Undergoing Chemotherapy

September 2009 - January 2012
Azacitidine and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia

December 2008 - January 2011
Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I Stage II or Stage III Non-Small Cell Lung Cancer

October 2005 - February 2008
Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone

March 2007 - November 2011
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

November 2005 - June 2008
Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers

July 1991 -
Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer

May 2009 - July 2010
Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer

April 1999 -
Bevacizumab Sorafenib and Temsirolimus in Treating Patients With Metastatic Kidney Cancer

September 2007 - May 2012
Erlotinib With or Without Carboplatin and Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

December 2008 - November 2010
Iodine I 131 Tositumomab Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Stage II Stage III or Stage IV Follicular Non-Hodgkin Lymphoma

September 2008 - October 2012
Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma

May 2005 - March 2010
Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy

June 2007 - January 2010
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer

July 2009 - August 2011
Idarubicin Cytarabine and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia

August 2009 - June 2011
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB Stage II or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery

June 2007 - July 2015
Breast Neoplasms

Colonic Neoplasms

Lung Neoplasms

Lymphoma

Lymphoma, Non-Hodgkin

Adenocarcinoma

Prostatic Neoplasms

Amyloidosis

Multiple Myeloma

Neoplasms, Plasma Cell

Leukemia

Neoplasms

Neoplasm Metastasis

Leukemia, Myeloid, Acute

Leukemia, Myeloid

Myelodysplastic Syndromes

Preleukemia

Leukemia, Myelomonocytic, Acute

Leukemia, Myelomonocytic, Chronic

Urinary Bladder Neoplasms

Carcinoma, Renal Cell

Kidney Neoplasms

Fatigue

Head and Neck Neoplasms

Carcinoma, Non-Small-Cell Lung

Bone Neoplasms

Bone Marrow Diseases

Carcinoma, Small Cell

Neurotoxicity Syndromes

Precancerous Conditions

Myeloproliferative Disorders

Colorectal Neoplasms

Carcinoma, Transitional Cell

Lymphoma, B-Cell

Lymphoma, Large B-Cell, Diffuse

Hematologic Neoplasms

Peripheral Nervous System Diseases

Demyelinating Diseases

Polyneuropathies

Neurologic Manifestations

Lymphoma, Follicular

Waldenstrom Macroglobulinemia

Ureteral Neoplasms

Osteonecrosis

Urologic Neoplasms

Monoclonal Gammopathies, Benign

Plasmacytoma

Paraproteinemias

Urethral Neoplasms

Placebo

Intensity-Modulated Radiation Therapy

Immunohistochemistry Staining Method

Laboratory Biomarker Analysis

Rituximab

Filgrastim

Celecoxib

Study Of Socioeconomic And Demographic Variables

Assessment Of Therapy Complications

Aflibercept

Paclitaxel

Carboplatin

Bevacizumab

Cisplatin

Docetaxel

Fluorouracil

Leucovorin Calcium

Dasatinib

Erlotinib Hydrochloride

Gemcitabine Hydrochloride

Gene Expression Analysis

Polymorphism Analysis

Cyclophosphamide

Prednisone

Pemetrexed Disodium

Capecitabine

3-Dimensional Conformal Radiation Therapy

Oxaliplatin

Cytarabine

Doxorubicin Hydrochloride

Etoposide

Vincristine Sulfate

Temsirolimus

Polymerase Chain Reaction

Sunitinib Malate

Microarray Analysis

Trastuzumab

Lapatinib Ditosylate

Cixutumumab

Sorafenib Tosylate

Fluorescence In Situ Hybridization

Azacitidine

Mutation Analysis

Cetuximab

Iodine I 131 Tositumomab

Biologic Sample Preservation Procedure

Study Of High Risk Factors

Matrix-Assisted Laser Desorption/Ionization Time Of Flight Mass Spectrometry

Irinotecan Hydrochloride

Ixabepilone

Gemtuzumab Ozogamicin

Paclitaxel Albumin-Stabilized Nanoparticle Formulation

Topotecan Hydrochloride

Pravastatin

Ac Regimen

Cytogenetic Analysis

Duloxetine Hydrochloride

Idarubicin

Vinorelbine Ditartrate

Entinostat

Placebo Administration

Tositumomab

Acetyl-L-Carnitine Hydrochloride

Chromogenic In Situ Hybridization

Fluorescent Antibody Technique

©2013 Applied Informatics, Inc.
As Seen On:
  • New York Times
  • USA Today
  • bio-itworld logo